We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Howmet Aerospace
HWM
$114B
| $44.7M | 0.11% |
2,819,307
-265,005
| -9% | -$3.48M |
|
202
American Electric Power
AEP
$69.7B
| $44.6M | 0.11% |
559,750
-6,200
| -1% | -$506K |
|
203
Marvell Technology
MRVL
$169B
| $44.5M | 0.11% |
1,270,461
-1,517,600
| -54% | -$44.4M |
|
204
Align Technology
ALGN
$12.3B
| $44.5M | 0.11% |
162,100
+110,900
| +217% | +$25M |
|
205
Legend Biotech
LEGN
$3.68B
| $44.1M | 0.11% |
+1,035,172
| New | +$40.4M |
|
206
Digital Realty Trust
DLR
$70.4B
| $44M | 0.11% |
309,900
+9,300
| +3% | +$1.32M |
|
207
Electronic Arts
EA
$53B
| $44M | 0.11% |
333,400
+1,900
| +0.6% | +$224K |
|
|
CMA
208
DELISTED
Comerica
CMA
| $43.3M | 0.11% |
1,136,916
+207,511
| +22% | +$7.24M |
|
209
DexCom
DXCM
$32.3B
| $43.3M | 0.11% |
427,076
+187,076
| +78% | +$16.7M |
|
210
General Mills
GIS
$19.2B
| $43.2M | 0.11% |
699,996
+10,900
| +2% | +$657K |
|
211
Enviri
NVRI
$637M
| $43.1M | 0.11% |
3,186,673
-618,129
| -16% | -$6.21M |
|
|
ABMD
212
DELISTED
Abiomed Inc
ABMD
| $42.8M | 0.11% |
177,013
+6,101
| +4% | +$1.23M |
|
213
Gen Digital
GEN
$16.7B
| $42.4M | 0.11% |
2,137,616
+35,957
| +2% | +$732K |
|
|
INFO
214
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $42.2M | 0.11% |
559,557
+104,500
| +23% | +$7.11M |
|
215
Duke Energy
DUK
$97.4B
| $42.2M | 0.11% |
528,760
-761,200
| -59% | -$64.3M |
|
216
Centene
CNC
$30.8B
| $42.1M | 0.11% |
662,912
-4,600
| -0.7% | -$299K |
|
217
AptarGroup
ATR
$8.68B
| $42M | 0.11% |
375,000
-75,000
| -17% | -$7.98M |
|
|
BNY
218
Bank of New York Mellon
BNY
$105B
| $41.5M | 0.11% |
1,073,550
-252,800
| -19% | -$9.25M |
|
219
Donaldson
DCI
$11.1B
| $41.2M | 0.11% |
+885,424
| New | +$39.1M |
|
220
Trane Technologies
TT
$101B
| $40.9M | 0.1% |
460,117
-20,436
| -4% | -$1.78M |
|
|
ETFC
221
DELISTED
E*Trade Financial Corporation
ETFC
| $40.8M | 0.1% |
819,905
+183,000
| +29% | +$7.88M |
|
222
Waste Management
WM
$89.9B
| $40.7M | 0.1% |
383,942
+359,924
| +1,499% | +$36.3M |
|
223
eBay
EBAY
$49B
| $40.3M | 0.1% |
768,800
+750,700
| +4,148% | +$31.7M |
|
|
TXNM
224
TXNM Energy Inc
TXNM
$6.38B
| $40.2M | 0.1% |
1,046,344
+171,609
| +20% | +$6.85M |
|
|
HOLX
225
DELISTED
Hologic
HOLX
| $39.9M | 0.1% |
699,376
-202,800
| -22% | -$9.95M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.